首页 › 基金 › RICE HALL JAMES & ASSOCIATES, LLC › MIRM

RICE HALL JAMES & ASSOCIATES, LLC 对 MIRM 的持仓历史

MIRUM PHARMACEUTICALS INC · 医疗保健

RICE HALL JAMES & ASSOCIATES, LLC 在 Q2 2026 的 13F 申报中披露持有 MIRM(MIRUM PHARMACEUTICALS INC)110,673 股,市值约 US$13.0M,约占其申报组合的 0.63%,在其申报持仓中市值排名第 50 位。 RICE HALL JAMES & ASSOCIATES, LLC 最近 12 个申报季度中有 12 个季度披露了 MIRM 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)110.67K 股
申报持仓市值$12.96M
组合权重0.63%
首次申报Q3 2023
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

RICE HALL JAMES & ASSOCIATES, LLC 对 MIRM 的持仓演变

RICE HALL JAMES & ASSOCIATES, LLC 于 Q3 2023 首次披露 MIRM 持仓:53,379 股(约 US$1.7M)。 该持仓在 Q1 2026 达到峰值 147,037 股,市值约 US$13.6M。 在 12 次申报中,RICE HALL JAMES & ASSOCIATES, LLC 3 次增持、7 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 110,673 股、市值约 US$13.0M,环比减持 -36,364 股。。 持仓曾出现大幅变动:Q1 2024 增持约 402% (随后一个季度股价上涨 36%)、Q3 2025 减持约 29% (随后一个季度股价上涨 8%)。

逐季持仓明细

季度股数金额变化
Q3 2023 53.38K $1.69M 新进
Q4 2023 42.84K $1.26M 减持
Q1 2024 214.89K $5.40M 增持
Q2 2024 229.73K $7.85M 增持
Q3 2024 242.71K $9.47M 增持
Q4 2024 239.00K $9.88M 减持
Q1 2025 234.70K $10.57M 减持
Q2 2025 231.99K $11.81M 减持
Q3 2025 164.75K $12.08M 减持
Q4 2025 164.45K $12.99M 持有
Q1 2026 147.04K $13.58M 减持
Q2 2026 110.67K $12.96M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MIRM 与 13F 数据

MIRM(MIRUM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 MIRM,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MIRM 的基金

查看 MIRM 的全部基金持有人 →

常见问题

How long has RICE HALL JAMES & ASSOCIATES, LLC held MIRM?

RICE HALL JAMES & ASSOCIATES, LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is RICE HALL JAMES & ASSOCIATES, LLC's current position in MIRM?

As of Q2 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 110.67K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $12.96M, representing 0.63% of its reported portfolio and ranking #50.

Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), RICE HALL JAMES & ASSOCIATES, LLC reduced its position in MIRM. The position peaked in Q1 2026 at 147.04K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.